(12/06/2024)vs ΕΛ.ΠΕ Β.Ε.Ε. | 24 | 10 | 0 / 00% | 5 / 1631.3% | 0 / 20% | 5 / 1827.8% | | 0 | 9 | 4 | 13 | 0 | 0 | 1 | 3 | 8 |
(31/05/2024)vs NICKAN | 17 | 8 | 0 / 30% | 4 / 850% | 0 / 30% | 4 / 1136.4% | | 4 | 2 | 1 | 3 | 1 | 0 | 0 | 3 | -1 |
(22/05/2024)vs NICKAN | 24 | 21 | 1 / 250% | 10 / 2050% | 0 / 30% | 10 / 2343.5% | | 0 | 8 | 5 | 13 | 4 | 3 | 1 | 1 | 27 |
(14/05/2024)vs SYNERGY TITANS | 24 | 7 | 1 / 250% | 3 / 1323.1% | 0 / 10% | 3 / 1421.4% | | 2 | 6 | 2 | 8 | 3 | 1 | 0 | 6 | 1 |
(24/04/2024)vs SYNERGY TITANS | 21 | 12 | 3 / 742.9% | 3 / 837.5% | 1 / 1100% | 4 / 944.4% | | 2 | 7 | 3 | 10 | 2 | 6 | 1 | 3 | 19 |
(08/04/2024)vs ΠΑΠΑΣΤΡΑΤΟΣ ΑΒΕΣ | 22 | 7 | 3 / 560% | 2 / 922.2% | 0 / 10% | 2 / 1020% | | 1 | 6 | 5 | 11 | 1 | 3 | 1 | 3 | 10 |
(03/04/2024)vs ΠΑΠΑΣΤΡΑΤΟΣ ΑΒΕΣ | 17 | 9 | 0 / 40% | 3 / 560% | 1 / 333.3% | 4 / 850% | | 1 | 3 | 2 | 5 | 1 | 0 | 0 | 3 | 4 |
(11/03/2024)vs LP CLINIC | 22 | 7 | 1 / 250% | 3 / 1127.3% | 0 / 30% | 3 / 1421.4% | | 2 | 7 | 1 | 8 | 2 | 3 | 1 | 3 | 6 |
(06/03/2024)vs NICKAN | 21 | 12 | 0 / 20% | 6 / 785.7% | 0 / 10% | 6 / 875% | | 3 | 5 | 0 | 5 | 2 | 3 | 1 | 2 | 17 |
(28/02/2024)vs ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ BC | 23 | 8 | 0 / 00% | 4 / 757.1% | 0 / 00% | 4 / 757.1% | | 2 | 5 | 0 | 5 | 2 | 2 | 0 | 2 | 12 |
(21/02/2024)vs Σ.Ε.ΤΑΠ. | 19 | 14 | 0 / 20% | 4 / 1040% | 2 / 540% | 6 / 1540% | | 1 | 4 | 3 | 7 | 1 | 3 | 0 | 1 | 13 |
(07/02/2024)vs PHARMACIA | 18 | 14 | 3 / 650% | 4 / 666.7% | 1 / 250% | 5 / 862.5% | | 0 | 3 | 0 | 3 | 4 | 2 | 1 | 4 | 14 |
(31/01/2024)vs COBALT | 21 | 11 | 1 / 333.3% | 5 / 5100% | 0 / 10% | 5 / 683.3% | | 0 | 4 | 0 | 4 | 1 | 4 | 2 | 2 | 17 |
(24/01/2024)vs NETCOMPANY INTRASOFT | 22 | 9 | 1 / 250% | 4 / 944.4% | 0 / 20% | 4 / 1136.4% | | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 7 | -4 |
(16/01/2024)vs SYNERGY TITANS | 30 | 15 | 4 / 666.7% | 4 / 944.4% | 1 / 425% | 5 / 1338.5% | | 1 | 3 | 3 | 6 | 8 | 6 | 0 | 1 | 24 |
ΣΥΝΟΛΙΚΑ |
325 |
164 |
18 / 4639.1% |
64 / 14344.8% |
6 / 3218.8% |
70 / 17540% |
|
20 |
73 |
30 |
103 |
32 |
36 |
9 |
44 |
167 |
ΜΕΣΟΙ ΟΡΟΙ |
21.7 |
10.9 |
1.2 / 3.139.1% |
4.3 / 9.544.8% |
0.4 / 2.118.8% |
4.7 / 11.740% |
|
1.3 |
4.9 |
2 |
6.9 |
2.1 |
2.4 |
0.6 |
2.9 |
11.1 |